Fujifilm Corp:企業の戦略的SWOT分析

◆英語タイトル:Fujifilm Corp - Strategic SWOT Analysis Review
◆商品コード:DATA904C15347
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:技術・通信
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Fujifilm Corp – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Fujifilm Corp (Fujifilm), a subsidiary of Fujifilm Holdings Corporation, is a provider of imaging and information solutions. The company’s product portfolio encompasses color films, optical devices, digital cameras, photofinishing equipment and color paper, chemicals and services for photofinishing, functional materials, graphic systems, recording media, electronic materials and industrial products, and office printers. It offers services to individual consumers and business enterprises. Fujifilm business products include medical systems, graphic systems, photofinishing products, motion picture products, optical devices, recording media, industrial products, semiconductor materials and biomaterials. The company conducts its business operations through its subsidiaries across the Americas, Europe, the Middle East and Africa, and Asia-Pacific. Fujifilm is headquartered in Tokyo, Japan.

Fujifilm Corp Key Recent Developments

Mar 05,2019: Probable Deal : Fujifilm and Tokyo Medical and Dental University conclude the patent licensing agreement on the world”s first autologous mesenchymal stem cell transplantation technology targeting meniscus injury.
Jan 15,2019: Fujifilm announces the extension of its Fill Finish services to include recombinant protein aseptic filling market
Jan 07,2019: Fujifilm’s $90M plan adds 100 jobs to biomanufacturing plant in Morrisville
Jan 06,2019: FUJIFILM Cellular Dynamics to establish new production facility for iPS cells for cell therapy.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
Section 1 – About the Company
Fujifilm Corp – Key Facts
Fujifilm Corp – Key Employees
Fujifilm Corp – Key Employee Biographies
Fujifilm Corp – Major Products and Services
Fujifilm Corp – History
Fujifilm Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Fujifilm Corp – Business Description
Fujifilm Corp – SWOT Analysis
SWOT Analysis – Overview
Fujifilm Corp – Strengths
Fujifilm Corp – Weaknesses
Fujifilm Corp – Opportunities
Fujifilm Corp – Threats
Fujifilm Corp – Key Competitors
Fujifilm Corp, Recent Deals Summary
Section 3 – Company’s Recent Developments
Mar 05, 2019: Probable Deal : Fujifilm and Tokyo Medical and Dental University conclude the patent licensing agreement on the world”s first autologous mesenchymal stem cell transplantation technology targeting meniscus injury.
Jan 15, 2019: Fujifilm announces the extension of its Fill Finish services to include recombinant protein aseptic filling market
Jan 07, 2019: Fujifilm’s $90M plan adds 100 jobs to biomanufacturing plant in Morrisville
Jan 06, 2019: FUJIFILM Cellular Dynamics to establish new production facility for iPS cells for cell therapy.
Jan 04, 2019: FUJIFILM Cellular Dynamics to establish new production facility for iPS cells for cell therapy
Jan 02, 2019: Fujifilm commits to further research on nucleic acid-liposome drug delivery system
Jan 02, 2019: Fujifilm commits to further research on nucleic acid-liposome drug delivery system.
Dec 10, 2018: Statement from Jeff Shuren, M.D., J.D., Director of the Center for Devices and Radiological Health, on updated safety communication about rates of duodenoscope contamination from preliminary postmarket data
Dec 06, 2018: Fujifilm Diosynth Biotechnologies announces co-chair role of its CEO, Steve Bagshaw, in the preparation of The United Kingdom’s bioeconomy growth strategy
Nov 15, 2018: Fujifilm showcases artificial intelligence initiative and advances AI Education at RSNA 2018
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Fujifilm Corp, Key Facts
Fujifilm Corp, Key Employees
Fujifilm Corp, Key Employee Biographies
Fujifilm Corp, Major Products and Services
Fujifilm Corp, History
Fujifilm Corp, Other Locations
Fujifilm Corp, Subsidiaries
Fujifilm Corp, Joint Venture
Fujifilm Corp, Key Competitors
Fujifilm Corp, Recent Deals Summary

★海外企業調査レポート[Fujifilm Corp:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The People’s Insurance Company (Group) of China Limited:企業の戦略・SWOT・財務情報
    The People's Insurance Company (Group) of China Limited - Strategy, SWOT and Corporate Finance Report Summary The People's Insurance Company (Group) of China Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • Fenner PLC (FENR):企業の財務・戦略的SWOT分析
    Summary Fenner PLC (Fenner) a subsidiary of Michelin SCA, is a provider of reinforced polymer technology. The company operates in the areas of advanced engineered products and engineered conveyor solutions. Its product portfolio includes heavyweight conveyor belt, high performance polymer components …
  • Concord Medical Services Holdings Ltd (CCM):企業の財務・戦略的SWOT分析
    Summary Concord Medical Services Holdings Ltd (CMS) is a diagnostic imaging center that offers clinical support services and laboratory services. The center offers radiotherapy and diagnostic imaging equipment services such as head gamma knife systems, body gamma knife systems and linear accelerator …
  • Vertex Pharmaceuticals Inc (VRTX)-製薬・医療分野:企業M&A・提携分析
    Summary Vertex Pharmaceuticals Inc (Vertex) is a biotechnology company that carries out the discovery, development and commercialization of novel drugs for the treatment of serious and life-threatening diseases. The company offers Orkambi (ivacaftor/lumacaftor) and Kalydeco (ivacaftor) for the treat …
  • Tatung Co. Ltd. (2371):企業の財務・戦略的SWOT分析
    Summary Tatung Co. Ltd. (Tatung) is an electronic product manufacturer that designs, manufactures, distributes and sells digital consumer products. The company operates through its business group such as power, consumer and system solution group. Its power business group provides transformers, switc …
  • Audentes Therapeutics Inc (BOLD)-製薬・医療分野:企業M&A・提携分析
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for serious and life-threatening rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myop …
  • Lanco Infratech Ltd (LITL):企業の財務・戦略的SWOT分析
    Lanco Infratech Ltd (LITL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Aurinia Pharmaceuticals Inc (AUP):企業の財務・戦略的SWOT分析
    Summary Aurinia Pharmaceuticals Inc (Aurinia Pharmaceuticals), formerly known as Isotechnika Pharma Inc, develops and commercialization of therapies. The company pipeline product Voclosporin, is used for the treatment of lupus nephritis (LN) and focal segmental glomerularsclerosis (FSGS); and voclos …
  • Domain Therapeutics SA-製薬・医療分野:企業M&A・提携分析
    Summary Domain Therapeutics SA (Domain Therapeutics) is a biopharmaceutical company that discovers and develops innovative therapeutics for the treatment of Central Nervous System (CNS) diseases and cancer by using transmembrane and G Protein-Coupled Receptor (GPCR) platform. Its pipeline consists o …
  • Subaru Corporation (7270):企業の財務・戦略的SWOT分析
    Subaru Corporation (7270) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PT. Matahari Putra Prima Tbk (MPPA):企業の財務・戦略的SWOT分析
    PT. Matahari Putra Prima Tbk (MPPA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Impel NeuroPharma Inc:医療機器:M&Aディール及び事業提携情報
    Summary Impel NeuroPharma Inc (Impel) is a clinical-stage biotechnology company that which develops intranasal drug treatments for central nervous system disorders. The company’s product pipeline includes INP104, INP103, INP102, INP101, INP105, and INP106. It also develops Precision Olfactory Delive …
  • LifeAssay Diagnostics (Pty) Ltd:企業の製品パイプライン分析2018
    Summary LifeAssay Diagnostics (Pty) Ltd (LifeAssay) is a medical device manufacturer. The company offers urine analysis, urine adulteration tests, lifestyle tests, lateral flow tests and industrial tests. It manufactures non-invasive semi-quantitative dipstick tests intended to measure selective phy …
  • ANS Group Plc:企業の戦略的SWOT分析
    ANS Group Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Banque Cramer & Cie SA:企業の戦略・SWOT・財務情報
    Banque Cramer & Cie SA - Strategy, SWOT and Corporate Finance Report Summary Banque Cramer & Cie SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Colbun SA (COLBUN):電力:M&Aディール及び事業提携情報
    Summary Colbun SA (Colbun) is an electric utility that generates and transmits electricity. It produces electricity from various sources including hydro, diesel, natural gas, coal, wind and biomass. The company has operating and developing interests in various power plants. Colbun also procures elec …
  • PG&E Corporation (PCG):電力:M&Aディール及び事業提携情報
    Summary PG&E Corporation (PG&E) is an energy holding company. It has interests in Pacific Gas and Electric Company. PG&E generates, transmits, and distributes electricity; and procures, transports, and stores natural gas. The company produces electricity from nuclear, hydro, fuel cell, solar, and fo …
  • Case Western Reserve University-製薬・医療分野:企業M&A・提携分析
    Summary Case Western Reserve University (CWRU) is a private research university that offers educational and research programs. The institute provides bachelor, master’s, doctoral and research programs through its colleges and professional schools, besides postdoctoral training. It offers courses in …
  • Daniel Thwaites Plc:企業の戦略・SWOT・財務分析
    Daniel Thwaites Plc - Strategy, SWOT and Corporate Finance Report Summary Daniel Thwaites Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Terumo BCT Inc-製薬・医療分野:企業M&A・提携分析
    Summary Terumo BCT Inc (Terumo BCT), a subsidiary of Terumo Corp, provides blood component, therapeutic apheresis, and cellular technologies. The company’s product portfolio include automated blood collection system, information system, data collection system, apheresis system, cell processor, cell …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆